JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW 31,950
-550 (-1.69%)
Apr 29, 2026, 1:20 PM KST
JW Pharmaceutical Revenue
In the year 2025, JW Pharmaceutical had annual revenue of 775.30B KRW with 7.77% growth. JW Pharmaceutical had revenue of 198.94B in the quarter ending December 31, 2025, with 5.90% growth.
Revenue
775.30B
Revenue Growth
+7.77%
P/S Ratio
0.96
Revenue / Employee
725.93M
Employees
1,068
Market Cap
741.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 775.30B | 55.92B | 7.77% |
| Dec 31, 2024 | 719.38B | -29.15B | -3.89% |
| Dec 31, 2023 | 748.53B | 64.18B | 9.38% |
| Dec 31, 2022 | 684.35B | 77.77B | 12.82% |
| Dec 31, 2021 | 606.58B | 59.25B | 10.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huons Global | 847.45B |
| Dong-A Socio Holdings | 1,429.77B |
| Bukwang Pharmaceutical | 200.71B |
| Boryung | 1,017.43B |
| Ildong Pharmaceutical | 566.93B |
| Shinpoong Pharmaceutical Co.,Ltd | 234.68B |
| Daewoong | 2,068.37B |
| DongKook Pharmaceutical | 926.88B |